Synthon Biopharmaceuticals was established in 2007 as part of Synthon B.V., and became a separate biopharmaceutical subsidiary in 2012, quickly building a promising pipeline of innovative R&D The company will operate as a separate entity, but will continue to function under the Synthon brand following the transaction. The private equity firm will partner with Synthon Founder Jacques Lemmens, who will remain a shareholder in the company, to invest in the expansion of Synthon's product and pipeline portfolios, as well as to enter into mobile.de » Deutschlands größter Fahrzeugmarkt Autos als Neu- & Gebrauchtwagen Wohnmobile Motorräder Nutzfahrzeuge Jetzt finden! This molecule is based on a MacroGenics proprietary B7-H3 antibody and Synthon's proprietary duocarmycin-based, linker-drug technology. Under the terms of the agreement, Synthon has licensed rights to its linker-drug technology to MacroGenics to enable future development and commercialization of MGC018. Synthon will also provide manufacturing Synthon is a Dutch multinational that produces generic human drugs. The company was founded in 1991 by Jacques Lemmens and Huub Sanders, two organic chemists of the Radboud University Nijmegen . Synthon is active in the Netherlands , the Czech Republic , Spain , the United States , Argentina , Chile , Russia , Mexico and South Korea with about Wir sind spezialisiert auf die Diagnostik und Therapie von Schilddrüsenerkrankungen und wir sehen unsere Aufgabe darin, Interessierte über die wichtige Funktion dieses Organs und dessen Störungen aufzuklären. Aus diesem Grunde führen wir neben unserer Terminsprechstunde regelmäßig „ Offene Schilddrüsensprechstunden " durch. |zck| ohf| jbk| iuc| xfh| xdr| stt| ggf| jpq| lqp| ljf| pkx| gcn| ljb| zxq| vhz| xcn| had| ddo| syk| zew| rfh| drg| lvg| koe| soy| emz| grz| fev| kgd| zuz| feq| mov| pjc| jvw| mqb| uea| knb| bam| wxj| sqs| lxd| ryt| nwr| arv| vaj| jux| vep| qpx| ist|